Table of Contents Table of Contents
Previous Page  26 / 78 Next Page
Information
Show Menu
Previous Page 26 / 78 Next Page
Page Background

26

Vol. 66, No. 4 2015

Northeast Florida Medicine

DCMS online

. org

Inflammatory Bowel Disease

6. Nikolaus S, Schreiber S. Diagnostics of inflammatory

bowel disease.

Gastroenterology.

2007 Nov;133(5):1670–

89.

7. Geboes K, Ectors N, D’Haens G, et al. Is ileoscopy with

biopsy worthwhile in patients presenting with symp-

toms of inflammatory bowel disease?

Am J Gastroenterol.

1998 Feb;93(2):201–6.

8. Castellaneta SP, Afzal NA, Greenberg M, et al. Diagnos-

tic role of upper gastrointestinal endoscopy in pediatric

inflammatory bowel disease.

J Pediatr Gastroenterol

Nutr.

2004 Sept;39(3):257–61.

9. Rutgeerts P, Onette E, Vantrappen G, et al. Crohn’s

disease of the stomach and duodenum: A clinical study

with emphasis on the value of endoscopy and endoscop-

ic biopsies.

Endoscopy.

1980 Nov;12(6):288–94.

10. Annunziata ML, Caviglia R, Papparella LG, et al.

Upper gastrointestinal involvement of Crohn’s disease: a

prospective study on the role of upper endoscopy in the

diagnostic work-up.

Dig Dis Sci.

2012 Jun;57(6):1618–

23.

11. Casella G, D’Inca R, Oliva L, et al. Prevalence of celiac

disease in inflammatory bowel diseases: An IG-IBD

multicentre study.

Dig Liver Dis.

2010 Mar;42(3):175–

8.

12. Lewis BS, Eisen GM, Friedman S. A pooled analysis to

evaluate results of capsule endoscopy trials.

Endoscopy.

2005 Oct;37(10):960–5.

13. Leighton JA. The role of endoscopic imaging of the

small bowel in clinical practice.

Am J Gastroenterol.

2011 Jan;106(1):27–36.

14. Mary JY, Modigliani R. Development and validation of

an endoscopic index of the severity for Crohn’s disease:

a prospective multicentre study. Groupe d’Etudes

Thérapeutiques des Affections Inflammatoires du Tube

Digestif (GETAID).

Gut.

1989 July;30(7):983–9.

15. Daperno M, D’Haens G, Van Assche G, et al. Devel-

opment and validation of a new, simplified endoscopic

activity score for Crohn’s disease: the SES-CD.

Gastro-

intest Endosc.

2004 Oct;60(4):505–12.

16. Colombel JF, Rutgeerts P, Reinisch W, et al. Early

mucosal healing with infliximab is associated with im-

proved long-term clinical outcomes in ulcerative colitis.

Gastroenterology.

2011 Oct;141(4):1194–201.

17. Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing

in inflammatory bowel disease: results from a Norwe-

gian population-based cohort.

Gastroenterology.

2007

Aug;133(2):412–22.

18. Fefferman DS, Farrell RJ. Endoscopy in inflamma-

tory bowel disease: indications, surveillance, and use

in clinical practice.

Clin Gastroenterol Hepatol.

2005

Jan;3(1):11–24.

19. Mary JY, Modigliani R. Development and validation of

an endoscopic index of the severity for Crohn’s disease:

a prospective multicentre study. Groupe d’Etudes

Thérapeutiques des Affections Inflammatoires du Tube

Digestif (GETAID).

Gut.

1989 July;30(7):983–9.

20. Daperno M, D’Haens G, Van Assche G, et al. Devel-

opment and validation of a new, simplified endoscopic

activity score for Crohn’s disease: the SES-CD.

Gastro-

intest Endosc.

2004 Oct;60(4):505–12.

21. Travis SP, Schnell D, Krzeski P, et al. Developing an

instrument to assess the endoscopic severity of ulcer-

ative colitis: the Ulcerative Colitis Endoscopic Index of

Severity (UCEIS).

Gut.

2012 Apr;61(4):535–42.

22. Samuel S, Bruining DH, Loftus Jr EV, et al. Validation

of the ulcerative colitis colonoscopic index of severity

and its correlation with disease activity measures.

Clin

Gastroenterol Hepatol.

2013 Jan;11(1)49-54.e1.

23. Annese V, Daperno M, Rutter MD, et al. European

evidence based consensus for endoscopy in inflammato-

ry bowel disease.

J Crohns Colitis.

2013 Dec;7(12):982-

1018.

24. Gasche C, Scholmerich J, Brjnskov J, et al. A simple

classification of Crohn’s disease: report of the Working

Party for the World Congresses of Gastroenterology,

Vienna 1998.

Inflamm Bowel Dis.

2000 Feb; 6(1): 8-15.

25. Gasche C, Scholmerich J, Brynskov J, et al. A simple

classification of Crohn’s disease: Report of the Working

Party for the World Congresses of Gastroenterology,

Vienna 1998.

Inflamm Bowel Dis.

2000 Feb; 6(1): 8-15.

26. Lichtenstein GR, Olson A, Travers S, et al. Factors

associated with the development of intestinal strictures

or obstructions in patients with Crohn’s disease.

Am J

Gastroenterol.

2006 May; 101(5):1030-1038.

27. Peyrin-Biroulet L, Loftus Jr EV, Colombel JF, et

al. The natural history of adult Crohn’s disease in

population-based cohorts.

Am J Gastroenterol.

2010

Feb;105(2):289–97.

28. Ozuner G, Fazio VW, Lavery IC, Milsom JW, et al.

Reoperative rates for Crohn’s disease following stric-

tureplasty. Long-term analysis.

Dis Colon Rectum.

1996

Nov;39(11):1199–203.

29. Hassan C, Zullo A, De Francesco V, et al. Systematic re-

view: Endoscopic dilatation in Crohn’s disease.

Aliment

Pharmacol Ther.

2007 Dec; 26(11-12): 1457-1464.

30. Hassan C, Zullo A, De Francesco Vet al. Systematic re-

view: Endoscopic dilatation in Crohn’s disease.

Aliment

Pharmacol Ther.

2007 Dec; 26(11-12): 1457-1464.

31. Morini S, Hassan C, Lorenzetti R, Zullo A, et al. Long-

term outcome of endoscopic pneumatic dilatation in

Crohn’s disease.

Dig Liver Dis.

2003 Dec;35(12):893–7.